Clinical Trials Browser

Phase 4 × INDUSTRY × Dermatologic × Clear all

Carcinoma, Non-Small-Cell Lung, Glioma, Lung Neoplasms, Melanoma

Melanoma, Skin Neoplasms

Carcinoma, Carcinoma, Basal Cell

Lymphoma, T-Cell, Cutaneous

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Melanoma

Keratosis, Actinic

Keratosis, Actinic

Keratosis, Keratosis, Actinic

Keratosis, Actinic

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

Melanoma, Neoplasm Metastasis, Skin Neoplasms

Keratosis, Actinic

Keratosis, Actinic

Keratosis, Actinic

Carcinoma, Renal Cell, Melanoma

Keratosis, Actinic

Keratosis, Actinic

Melanoma, Skin Neoplasms

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Keratosis, Actinic

Keratosis, Actinic

Skin Neoplasms

Keratosis, Keratosis, Actinic

Keratosis, Keratosis, Actinic

Keratosis, Actinic

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous

Keratosis, Keratosis, Actinic

Clinical Trials

Dabrafenib and/or Trametinib Rollover Study

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China

A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy

Keynote-593

Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

AKtive

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

PROCLIVITY02

Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial

LEIDA

LEIDA 2

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® Photodynamic Therapy (PDT)

SESAME 2

PROCLIVITY01

An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis

Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis

Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses

An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses

Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients

Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients

Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands